The pooled ORs demonstrated that MBL2 H > L gene polymorphism is not associated with TB risk in allelic contrast (L vs. H: p = 0.757; OR = 1.019, 95% CI = 0.904 to 1.149), homozygous (LL vs. HH: p = 0.561; OR = 0.907, 95% CI = 0.653 to 1.260), heterozygous (HL vs. LL: p = 0.651; OR = 0.905, 95% CI = 0.588 to 1.394), dominant (HH + HL vs. LL: p = 0.491; OR = 0.915, 95% CI = 0.710 to 1.179), and recessive (HH vs. LL + HL: p = 0.742; OR = 0.935, 95% CI = 0.626 to 1.396) genetic models (Fig. 7). This evidence concerns the gene MBL2 and tuberculosis.